Finance

Lists
BBNX:NASDAQ
Beta Bionics Inc
$ 18.86
-0.53%
(-0.100) 1D
10-р сарын 5, 15:29:06 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BBNX...
Open
$ 18.91
High
$ 19.26
Low
$ 18.74
Mkt. cap
992.67 сая
Avg. vol.
1.27 сая
Volume
324.69 мян
52-wk high
$ 32.71
52-wk low
$ 8.80
EPS
-$ 1.65
Shares outstanding
52.64 сая
No. of employees
422
Open
$ 18.91
High
$ 19.26
Low
$ 18.74
Mkt. cap
992.67 сая
Avg. vol.
1.27 сая
Volume
324.69 мян
52-wk high
$ 32.71
52-wk low
$ 8.80
EPS
-$ 1.65
Shares outstanding
52.64 сая
No. of employees
422
News stories
From web sources and news partners
About Beta Bionics Inc
CEO-
Employees422
Founded2015
HeadquartersИрвин, Калифорни, Америкийн Нэгдсэн Улс
Sector-
Websitebetabionics.com
Analyst ratings
Based on 13 analysts giving stock ratings to BBNX in the past 3 months
Buy
Buy
9
Hold
4
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for BBNX in the last 3 months.
Highest
Current $ 18.86
$ 30.40 (+61.19%)
Average
$ 23.20 (+23.01%)
Lowest
$ 16.00 (-15.16%)
Analyst
Recommendation
Action
Price target
Projected
Date
Richard Newitter
Truist Financial
Buy
Reiterated
$ 28.00
+48.5%
09/24/2026
Larry Biegelsen
Wells Fargo
Buy
Initiated
$ 28.00
+48.5%
09/23/2026
Frank Takkinen
Lake Street
Buy
Reiterated
$ 25.00
+32.6%
09/22/2026
Mike Kratky
Leerink Partners
Buy
Reiterated
$ 27.00
+43.2%
09/17/2026
Jonathan Block
Stifel Nicolaus
Buy
Maintained
$ 22.00
+16.6%
09/15/2026
Jeff Johnson
Robert W. Baird
Hold
Maintained
$ 16.00
-15.2%
09/15/2026
Patrick Wood
UBS
Buy
Maintained
$ 25.00
+32.6%
09/15/2026
Travis Steed
Bank of America Securities
Hold
Reiterated
$ 20.00
+6%
09/14/2026
Mathew Blackman
TD Cowen
Hold
Maintained
$ 18.00
-4.6%
09/14/2026
Steven Lichtman
William Blair
Hold
Maintained
-
-
09/14/2026
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Reiterated
$ 30.40
+61.2%
07/30/2026
Matthew O'Brien
Piper Sandler
Buy
Reiterated
$ 20.00
+6%
07/30/2026
Danielle Antalffy
UBS
Buy
Initiated
$ 22.00
+16.6%
07/28/2026
David Roman
Goldman Sachs
Buy
Reiterated
$ 19.00
+0.7%
07/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
27.25 сая
32.12 сая
27.63 сая
32.01 сая
Cost of goods sold
12.13 сая
13.18 сая
11.19 сая
13.11 сая
Cost of revenue
12.13 сая
13.18 сая
11.19 сая
13.11 сая
Research and development expenses
8.20 сая
10.13 сая
10.36 сая
10.24 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23.97 сая
24.94 сая
30.35 сая
34.24 сая
Operating expense
32.16 сая
35.07 сая
40.71 сая
44.48 сая
Total operating expenses
44.30 сая
48.24 сая
51.90 сая
57.59 сая
Operating income
-17.04 сая
-16.12 сая
-24.27 сая
-25.58 сая
Other non operating income
1.00 мян.
-
-
-2.00 мян
EBT including unusual items
-14.21 сая
-13.47 сая
-21.90 сая
-23.40 сая
EBT excluding unusual items
-14.21 сая
-13.47 сая
-21.90 сая
-23.40 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14.21 сая
-13.47 сая
-21.90 сая
-23.40 сая
Net profit margin
-52.14%
-41.92%
-79.25%
-73.10%
Earnings per share
-0.33
-0.19
-0.36
-0.36
Interest and investment income
2.83 сая
2.66 сая
2.38 сая
2.18 сая
Interest expense
-
-
-
-
Net interest expenses
2.83 сая
2.66 сая
2.38 сая
2.18 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-16.66 сая
-15.59 сая
-23.69 сая
-24.87 сая
Gain or loss from assets sale
-
31.00 мян
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google аппс